FIELD: chemistry.
SUBSTANCE: described is a new uniformly tritium-labeled 4,4-fluoro-N-{(1S)-3-[3-(3-isopropyl-5-methyl-4H-1,2,4-trizol-4-yl)-8-azabicyclo[3.2.1]oct-8-yl]-1-phenylpropyl}cyclohexane carboiimide (maraviroc) of formula I .
EFFECT: said compound can be used in analysis of physiologically active compound-analogue.
1 cl, 1 ex, 2 dwg
Title | Year | Author | Number |
---|---|---|---|
1-(3-AMINOPROPYL)-SUBSTITUTED CYCLIC AMINE COMPOUNDS, PREPARATION METHOD THEREFOR AND PHARMACEUTICAL COMPOSITIONS AND USES THEREOF | 2014 |
|
RU2671179C2 |
TRITIUM-LABELLED 3-[5-(2-FLUROPHENYL)-1,2,4-OXADIAZOL-3-YL]BENZOIC ACID | 2009 |
|
RU2398770C1 |
3,3-DISUBSTITUTED-(8-AZABICYCLO[3.2.1]OCTA-8-YL)-[5-(1H-PYRASOL-4-YL)-THIOPHEN-3-YL]- METHANONE AND RELATED COMPOUNDS AND THEIR USE | 2011 |
|
RU2593753C2 |
TRITIUM-LABELED ACYL-COENZYME A | 2006 |
|
RU2305104C1 |
CHLOROHEXIDINE HIGHLY LABELED WITH TRITIUM | 2005 |
|
RU2309929C2 |
4-(IMIDAZO[1,2-A]PYRIDIN-3-YL)-PYRIMIDINE DERIVATIVES | 2020 |
|
RU2822388C2 |
UNIFORMLY MARKED WITH TRITIUM TILOSIN | 2008 |
|
RU2360896C1 |
TRITIATED 3,7-BIS(2,3-DIHYDRO-1-BENZOFURAN-5-YLCARBONYL)-1,5-DIMETHYL-3,7-DIAZABICYCLO[3.3.1]NONAN-9-ONE | 2017 |
|
RU2668982C1 |
2-AMINO-4-(β-HYDROXYETHYLAMINO)ANISOLE UNIFORMLY LABELED WITH TRITIUM | 2005 |
|
RU2291142C1 |
METHOD FOR PREDICTING THE THERAPEUTIC EFFECT OF AN LSD 1INHIBITOR BASED ON THE INSM1 EXPRESSION | 2018 |
|
RU2789449C2 |
Authors
Dates
2009-09-27—Published
2008-02-19—Filed